Changeflow GovPing Healthcare & Life Sciences Observational Study on Quran Recital Effects in...
Routine Notice Added Final

Observational Study on Quran Recital Effects in MS Patients

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

An observational clinical trial has been registered on ClinicalTrials.gov under NCT07544303 to evaluate the effects of Quran recital on fatigue and mental well-being in patients with multiple sclerosis. The study will call patients to assess continued Quran recital practice, with the control group continuing routine treatment and no additional intervention. Final measurements will be conducted in-person at the hospital at the end of week four. The estimated study completion date is April 22, 2026.

“This study will be conducted to evaluate the effects of Quran recital on fatigue and mental well-being in patients with multiple sclerosis.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

A new observational clinical trial has been registered on ClinicalTrials.gov studying the effect of Quran recital on fatigue and mental well-being in multiple sclerosis patients. Patients in the intervention group will practice Quran recital and be followed by the researcher, while the control group will continue routine treatment with no additional intervention. Final assessments will be conducted at an in-person hospital visit at the end of the four-week study period.

Healthcare providers and clinical investigators involved in MS care or non-pharmacological intervention research may find this registry relevant for identifying active studies in complementary and spiritual approaches to managing MS symptoms. The study represents an emerging area of research interest in integrative healthcare interventions for neurological conditions.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Fatigue and Mental Well-Being in MS Patients(Multiple Sclerosis)

N/A NCT07544303 Kind: NA Apr 22, 2026

Abstract

This study will be conducted to evaluate the effects of Quran recital on fatigue and mental well-being in patients with multiple sclerosis.

Hypotheses:

  1. Quran recital reduces fatigue in MS patients.
  2. Quran recital increases mental well-being in MS patients. The patients will be called by the researcher to ask whether they continue this practice. The control group will continue their routine treatment and care and no additional intervention will be applied. The final test measurements will be made by meeting with the patients in the hospital at the end of the 4th week.

Conditions: Multiple Sclerosis

Interventions: Quran recital

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07544303

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical research Patient treatment
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Healthcare

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!